EyEnovIA, Inc. Files 8-K: Other Events
Ticker: HYPD · Form: 8-K · Filed: Nov 20, 2024 · CIK: 1682639
| Field | Detail |
|---|---|
| Company | Eyenovia, INC. (HYPD) |
| Form Type | 8-K |
| Filed Date | Nov 20, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $0.7 million, $10.1 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, other-events
Related Tickers: EYEN
TL;DR
EYEN just dropped an 8-K for 'Other Events' - need to see what's up.
AI Summary
On November 19, 2024, EyEnovIA, Inc. filed an 8-K report. The filing indicates an 'Other Events' category, suggesting a significant, non-routine event has occurred. Specific details regarding the nature of this event, any associated financial implications, or parties involved are not provided in the excerpt.
Why It Matters
This filing signals a material event for EyEnovIA, Inc. that requires immediate disclosure to investors, though the specific nature of the event is not yet detailed.
Risk Assessment
Risk Level: medium — The 'Other Events' designation on an 8-K often signifies significant, potentially impactful news that could affect the company's stock price, but the lack of detail requires further investigation.
Key Players & Entities
- EYENOVIA, INC. (company) — Registrant
- November 19, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-38365 (identifier) — Commission File Number
- 47-1178401 (identifier) — IRS Employer Identification No.
- 295 Madison Avenue, Suite 2400, New York, NY 10017 (address) — Principal Executive Offices
- ( 833 ) 393-6684 (phone_number) — Registrant's Telephone Number
FAQ
What specific event triggered the 'Other Events' filing for EyEnovIA, Inc. on November 19, 2024?
The provided excerpt does not specify the exact event; it only indicates that the filing pertains to 'Other Events'.
What is the significance of an 'Other Events' filing on a Form 8-K?
An 'Other Events' filing on a Form 8-K is used to report material events that do not fit into the other categories of Form 8-K, often signaling significant corporate developments.
Where are EyEnovIA, Inc.'s principal executive offices located?
EyEnovIA, Inc.'s principal executive offices are located at 295 Madison Avenue, Suite 2400, New York, NY 10017.
What is EyEnovIA, Inc.'s Commission File Number?
EyEnovIA, Inc.'s Commission File Number is 001-38365.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on November 19, 2024.
Filing Stats: 705 words · 3 min read · ~2 pages · Grade level 12.9 · Accepted 2024-11-20 08:00:13
Key Financial Figures
- $0.0001 — h registered) Common stock, par value $0.0001 per share EYEN The Nasdaq Stock Mar
- $0.7 million — pany") had cash and cash equivalents of $0.7 million. In addition, the Company is in discus
- $10.1 million — of November 19, 2024, the Company owed $10.1 million in principal and accrued interest under
Filing Documents
- tm2428958d1_8k.htm (8-K) — 25KB
- 0001104659-24-120867.txt ( ) — 194KB
- eyen-20241119.xsd (EX-101.SCH) — 3KB
- eyen-20241119_lab.xml (EX-101.LAB) — 33KB
- eyen-20241119_pre.xml (EX-101.PRE) — 22KB
- tm2428958d1_8k_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. As of November 19, 2024, Eyenovia, Inc. (the "Company") had cash and cash equivalents of $0.7 million. In addition, the Company is in discussions with Avenue Capital Management L.P. ("Avenue") regarding a potential restructuring of the amounts owed by the Company under its Loan and Security Agreement with Avenue and related entities (the "Agreement"). As of November 19, 2024, the Company owed $10.1 million in principal and accrued interest under the Agreement. The Avenue loan bears interest at an annual rate equal to the greater of (a) 7.0% and (b) the prime rate as reported in The Wall Street Journal plus 4.45%. The maturity date is November 1, 2025. As previously disclosed, the Company also continues to consider a variety of steps to maximize value to all stakeholders, to reduce expenses and to evaluate its strategic options, which may include a business combination, reverse merger, asset sales or a combination of those alternatives. Further information will be made available once the evaluation of strategic options has been completed.
Forward-Looking Statements
Forward-Looking Statements Except for historical information, all the statements, expectations and assumptions contained in this Current Report on Form 8-K are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express the Company's intentions, beliefs, expectations, strategies, predictions or any other statements relating to the Company's future activities or other future events or conditions, including statements regarding the potential restructuring of the Company's outstanding debt and potential strategic alternatives. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and in some cases are likely to, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors discussed from time to time in documents which the Company files with the Securities and Exchange Commission. Any forward-looking statements speak only as of the date on which they are made, and except as may be required under applicable securities laws, the Company does not undertake any obligation to update any forward-looking statements.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EYENOVIA, INC. Dated: November 20, 2024 By: /s/ Andrew Jones Andrew Jones Chief Financial Officer